I agree that this site is using cookies. You can find further informations here.
X
Rufibach, Kaspar
148  results:
Search for persons X
?
1

Applying the estimand and target trial frameworks to extern..:

Polito, Letizia ; Liang, Qixing ; Pal, Navdeep...
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Implementation of Statistical Innovation in a Pharmaceutica..:

Rufibach, Kaspar ; Wolbers, Marcel ; Devenport, Jenny...
Statistics in Biopharmaceutical Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
3

Survival analysis for AdVerse events with VarYing follow-up..:

Rufibach, Kaspar ; Beyersmann, Jan ; Friede, Tim..
Trials.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

Quantification of follow‐up time in oncology clinical trial..:

Rufibach, Kaspar ; Grinsted, Lynda ; Li, Jiang...
Pharmaceutical Statistics.  22 (2023)  4 - p. 671-691 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Modified study designs to expand treatment options in perso..:

Le Tourneau, Christophe ; André, Fabrice ; Helland, Åslaug...
European Journal of Cancer.  194 (2023)  - p. 113278 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Cancer Clinical Trials beyond Pandemic: Report of an Americ..:

Sridhara, Rajeshwari ; Barksdale, Elizabeth ; Marchenko, Olga...
Statistics in Biopharmaceutical Research.  15 (2022)  2 - p. 444-449 , 2022
Link: https://doi.org/10.1080/..
 
?
7

Clinical and Statistical Perspectives on the ICH E9(R1) Est..:

Ionan, Alexei C. ; Paterniti, Miya ; Mehrotra, Devan V....
Statistics in Biopharmaceutical Research.  15 (2022)  3 - p. 554-559 , 2022
Link: https://doi.org/10.1080/..
 
?
8

Estimands and Complex Innovative Designs:

Collignon, Olivier ; Schiel, Anja ; Burman, Carl‐Fredrik...
Clinical Pharmacology & Therapeutics.  112 (2022)  6 - p. 1183-1190 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Comparison of Adverse Event Risks in Randomized Controlled ..:

Rufibach, Kaspar ; Stegherr, Regina ; Schmoor, Claudia...
Statistics in Biopharmaceutical Research.  15 (2022)  4 - p. 767-780 , 2022
Link: https://doi.org/10.1080/..
 
?
10

Conditional power and friends: The why and how of (un)plann..:

Kunzmann, Kevin ; Grayling, Michael J. ; Lee, Kim May...
Statistics in Medicine.  41 (2022)  5 - p. 877-890 , 2022
Link: https://doi.org/10.1002/..
 
?
11

On Identification of the Principal Stratum Effect in Patien..:

Dukes, Oliver ; Van Lancker, Kelly ; Bornkamp, Björn...
Statistics in Biopharmaceutical Research.  13 (2021)  4 - p. 508-510 , 2021
Link: https://doi.org/10.1080/..
 
?
12

Estimands for overall survival in clinical trials with trea..:

Manitz, Juliane ; Kan‐Dobrosky, Natalia ; Buchner, Hannes...
Pharmaceutical Statistics.  21 (2021)  1 - p. 150-162 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Principal stratum strategy: Potential role in drug developm..:

Bornkamp, Björn ; Rufibach, Kaspar ; Lin, Jianchang...
Pharmaceutical Statistics.  20 (2021)  4 - p. 737-751 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Phase III Clinical Trials in First-Line Follicular Lymphoma..:

Bachy, Emmanuel ; Rufibach, Kaspar ; Parreira, Joana...
Advances in Therapy.  , 2021
Link: https://doi.org/10.1007/..
 
?
15

A Review of Bayesian Perspectives on Sample Size Derivation..:

Kunzmann, Kevin ; Grayling, Michael J. ; Lee, Kim May...
The American Statistician.  75 (2021)  4 - p. 424-432 , 2021
Link: https://doi.org/10.1080/..
 
1-15